Table 2 Number of end point events and covariate-adjusted ORs in overall cohort
From: Preoperative beta-blocker in ventricular dysfunction patients: need a more granular quality metric
End point | No. (%) of events by group | OR (95% CI) | P | |
|---|---|---|---|---|
No beta-blocker (n = 2343) | Beta-blocker (n = 3773) | |||
Mortality | 87 (3.7) | 113 (3.0) | 0.82 (0.58–1.15) | 0.256 |
Re-intubation | 60 (2.6) | 91 (2.4) | 1.03 (0.69–1.54) | 0.869 |
Postoperative MI | 24 (1.0) | 24 (0.6) | 0.95 (0.44–2.07) | 0.894 |
Mediastinal infection | 19 (0.8) | 28 (0.7) | 0.92 (0.45–1.89) | 0.825 |
Postoperative AF | 634 (27.1) | 1089 (28.9) | 1.07 (0.94–1.21) | 0.135 |
Postoperative stroke | 17 (0.7) | 12 (0.3) | 0.37 (0.16–0.96) | 0.040 |
Postoperative renal failure | 43 (1.8) | 62 (1.6) | 0.85 (0.53–1.36) | 0.494 |
MODS | 43 (1.8) | 62 (1.6) | 0.99 (0.56–1.75) | 0.975 |
Re-operation | 37 (1.6) | 90 (2.4) | 1.31 (0.85–2.02) | 0.228 |